Carlsmed, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Carlsmed, Inc. (CARL) reported Net Income (Loss) Available to Common Stockholders, Basic of -$10.51 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-05
- Carlsmed, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$10.51M.
- Carlsmed, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$8.70M.
- Carlsmed, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$8.61M.
- Carlsmed, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$8.53M.
- Carlsmed, Inc. net income (loss) available to common stockholders, basic for fiscal 2025 was -$30.22M.
- Carlsmed, Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was -$24.85M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.51M 10-Q · filed 2026-08-05 | -$19.21M 10-Q · filed 2026-08-05 | -$27.82M derived: sum of 3 quarters · filed 2026-08-05 | -$36.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$8.70M 10-Q · filed 2026-05-05 | -$17.31M derived: sum of 2 quarters · filed 2026-05-05 | -$25.84M derived: sum of 3 quarters · filed 2026-05-05 | -$32.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$8.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$17.14M derived: sum of 2 quarters · filed 2026-02-25 | -$23.91M derived: sum of 3 quarters · filed 2026-08-05 | -$30.22M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$8.53M 10-Q · filed 2025-11-06 | -$15.29M derived: sum of 2 quarters · filed 2026-08-05 | -$21.61M 10-Q · filed 2025-11-06 | -$26.32M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$6.77M 10-Q · filed 2026-08-05 | -$13.08M 10-Q · filed 2026-08-05 | -$17.80M derived: sum of 3 quarters · filed 2026-08-05 | -$26.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$6.31M 10-Q · filed 2026-05-05 | -$11.03M derived: sum of 2 quarters · filed 2026-05-05 | -$19.44M derived: sum of 3 quarters · filed 2026-05-05 | -$25.71M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$13.13M derived: sum of 2 quarters · filed 2026-02-25 | -$19.40M derived: sum of 3 quarters · filed 2026-02-25 | -$24.85M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$8.40M 10-Q · filed 2025-11-06 | -$14.68M derived: sum of 2 quarters · filed 2025-11-06 | -$20.13M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$6.28M 10-Q · filed 2025-08-28 | -$11.72M 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |